The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken

The current analysis investigated the prognostic significance of gadopentetate dimeglumine on survival and renal function in patients with monoclonal plasma cell disorders.

Bibliographic Details

Main Authors:	Hillengaß, Jens (Author) , Stoll, Johanna (Author) , Zechmann, Christian (Author) , Kunz, Christina (Author) , Wagner, Barbara (Author) , Heiß, Christiane (Author) , Sumkauskaite, Migle (Author) , Möhler, Thomas (Author) , Schlemmer, Heinz-Peter (Author) , Goldschmidt, Hartmut (Author) , Delorme, Stefan (Author)
Format:	Article (Journal)
Language:	English
Published:	2015
In:	European radiology Year: 2014, Volume: 25, Issue: 3, Pages: 745-750
ISSN:	1432-1084
DOI:	10.1007/s00330-014-3458-5
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00330-014-3458-5
Author Notes:	J. Hillengass, J. Stoll, C.M. Zechmann, C. Kunz, B. Wagner, C. Heiss, M. Sumkauskaite, T.M. Moehler, H.P. Schlemmer, H. Goldschmidt, S. Delorme